Skip to content
healthcare.dev
Get a free key

Gomekli

NDC 82448-134, mirdametinib, tablet, for suspension, from SpringWorks Therapeutics, Inc..

Product NDC
82448-134
Status
Listed
Labeler
SpringWorks Therapeutics, Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219379
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82448-134 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRDAMETINIB1 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]; Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]

Package NDCNDC-11Package
82448-134-428244801344242 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-42)
82448-134-848244801348484 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-84)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4c41bf90-5fa7-4935-a95c-e047ea6bbf8e

Use it

Look up 82448-134 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82448-134 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82448-134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.